IDENTIFICATION OF NOVEL INHIBITORS FOR MITOGEN-ACTIVATED PROTEIN KINASE KINASE 4 BY VIRTUAL SCREENING AND MOLECULAR DYNAMICS SIMULATION TECHNIQUES
Keywords:
Molecular Dynamics Simulation, Virtual Screening, Molecular Docking, Prostate Cancer, ERK Kinase-1, MKK4Abstract
Objective: The objective of this study was to discover a therapeutic natural lead compound against mitogen-activated protein kinase kinase 4 (MKK4) employing in silico studies.
Methods: In the present study, natural compounds database was first screened for potent inhibitory activity by employing a high throughput virtual screening and molecular docking. The molecular dynamic simulation was used to analyze the stability of ligands.
Results: Top ten hit compounds obtained from virtual screening and molecular docking were analyzed for their binding poses. Molecular docking studies reveal that all ten compounds bind into the same binding pocket. Molecular dynamic simulation of ZINC06091752-MKK4 and ZINC00391412-MKK4 complexes revealed stable and potential binding mode of MKK4 to ZINC06091752 and ZINC00391412.
Conclusion: The potential binding mode of MKK4 to ZINC06091752 and ZINC00391412 was explored through molecular dynamic simulations. ZINC06091752 and ZINC00391412 have been identified as potential inhibitors of MKK4. Analysis of ligand efficiency profiles through assays would add more value to the current findings and may be beneficial in prostate cancer therapy.
Keywords: Molecular Dynamics Simulation, Virtual Screening, Molecular Docking, Prostate Cancer, ERK Kinase-1, MKK4
Downloads
References
Siegel R, Miller K, Jemal A. Cancer statistics. CA Cancer J Clin 2016;66:7-30.
Cuenda A. Mitogen-activated protein kinase kinase 4 (MKK4). Int J Biochem Cell Biol 2000;32:581–7.
Whitmarsh AJ, Davis RJ. Role of mitogen-activated protein kinase kinase 4 in cancer. Oncogene 2007;26:3172–84.
Pavese JM, Ogden IM, Voll EA, Huang X, Xu L, Jovanovic B, et al. Mitogen-activated protein kinase kinase 4 (MAP2K4) promotes human prostate cancer metastasis. PloS One 2014;9:e102289. Doi:10.1371/journal.pone.0102289. [Article in Press]
Szmulewitz RZ, Clark R, Lotan T, Otto K, Taylor J, Veneris K, et al. MKK4 suppresses metastatic colonization by multiple highly metastatic prostate cancer cell lines through a transient impairment in cell cycle progression. Int J Cancer 2012;130:509–20.
Matsumoto T. Crystal structures of MKK4 kinase domain reveal that peptide substrate binds to an allosteric site and induces an auto-inhibition state. Biochem Biophys Res Commun 2010;400:369–73.
Berman HM, Battistuz T, Bhat TN, Bluhm WF, Bourne PE, Burkhardt K, et al. The protein data bank. Acta Crystallogr Sect D: Biol Crystallogr 2002;58:899–907.
MacroModel. Schrodinger LLC, New York: USA; 2011.
LigPrep. Schrodinger LLC, New York: USA; 2011.
Friesner RA, Murphy RB, Repasky MP, Frye LL, Greenwood JR, Halgren TA, et al. Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. J Med Chem 2006;19:6177–96.
Qikprop. Schrodinger LLC, New York, USA; 2011.
Irwin JJ, Sterling T, Mysinger MM, Bolstad ES, Coleman RG. ZINC: a free tool to discover chemistry for biology. J Chem Inf Model 2012;52:1757–68.
Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Delivery Rev 2001;46:3–26.
Shivakumar D, Williams J, Damm W, Shelley J, Sherman W. Prediction of absolute solvation free energies using molecular dynamics free energy perturbation and the opls force field. J Chem Theory Comput 2010;6:1509–19.
Branka A. Nose-hoover chain method for nonequilibrium molecular dynamics simulation. Phys Rev 2000;61:4769–73.
Martyna GJ, Tobias DJ, Klein ML. Constant pressure molecular dynamics algorithms. J Chem Phys 1994;101:4177-89.
Vincent K, van G, Philippe HH. A fast SHAKE algorithm to solve distance constraint equations for small molecules in molecular dynamics simulations. J Comput Chem 2001;22:501–8.
Kinnings SL, Jackson RM. Binding site similarity analysis for the functional classification of the protein kinase family. J Chem Inf Model 2009;49:318–29.
Liao JJ. Molecular recognition of protein kinase binding pockets for the design of potent and selective kinase inhibitors. J Med Chem 2007;50:409–24.
Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase in vitro and in vivo. J Biochem 1995;270:27489–94.
Gum RJ, McLaughlin MM, Kumar S, Wang Z, Bower MJ. Acquisition of sensitivity of stress-activated protein kinases to the p38 inhibitor, SB 203580, by alteration of one or more amino acids within the ATP binding pocket. J Biol Chem 1998;273:15605–10.
Kim N, Park J, Gadhe CG, Cho SJ, Oh Y. A protoberberine derivative HWY336 selectively inhibits MKK4 and MKK7 in mammalian cells: the importance of activation loop on selectivity. PLoS One 2014;9:e91037. Doi:10.1371/ journal. pone.0091037. [Article in Press]
Scheiner S, Kar T, Gu Y. The strength of the C H O hydrogen bond of amino acid residues. J Biol Chem 2001;276:9832–7.
Bissantz C, Kuhn B, Stahl M. A medicinal chemist’s guide to molecular interactions. J Med Chem 2010;53:5061–84.